Nate Jung

Virginia Mason Medical Center

Papers

1

Total Citations

3

H-Index

1

About

Nate Jung is a urologic oncologist whose research focuses on surgical outcomes and health disparities in prostate cancer treatment. His most cited work, a 2022 study on "Prospective quality of life in men choosing open vs. robotic radical prostatectomy," draws from a racially diverse multi-institutional database to provide long-term insights into patient-reported outcomes. This research is pivotal in understanding how surgical approach—open versus robotic—affects quality of life, particularly in underrepresented populations. Jung's contributions lie in bridging the gap between surgical innovation and real-world patient experiences, emphasizing the importance of diversity in clinical data. While his citation count is still growing, his work has already informed discussions on personalized surgical decision-making and equity in cancer care. Jung's dedication to prospective, patient-centered research marks him as an emerging voice in urologic oncology, with potential to shape future guidelines for prostate cancer management.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Prospective quality of life in men choosing open vs. robotic radical prostatectomy: long-term results from a racially diverse multi-institutional database
3 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Virginia Mason Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago